Maxcyte (MXCT) Debt Ratio (2020)
Maxcyte's (MXCT) quarterly Debt Ratio came in at 0.09 in Q4 2020.
Powered by 
Analysis
Maxcyte (MXCT) Debt Ratio (2020) Analysis & Trends
Maxcyte (MXCT) has reported Debt Ratio for 1 consecutive years, with 0.09 the latest figure, recorded in Q4 2020.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.09 in Q4 2020; TTM through Dec 2020 was 0.09, a N/A change from a year earlier, with the FY2020 full-year figure at 0.09, changed N/A from the prior year.
- Debt Ratio was 0.09 for Q4 2020 at Maxcyte.
- Over five years, Debt Ratio peaked at 0.09 in Q4 2020 and troughed at 0.09 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 0.40 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 0.30 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 0.30 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 0.30 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 0.27 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 0.08 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 0.16 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 0.19 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Maxcyte | 131.93 Mn | 131.93 Mn | 5.60 Mn | - |